Zingiberene, a non-zinc-binding class I HDAC inhibitor: A novel strategy for the management of neuropathic pain
Open Access
- 13 January 2023
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 111, 154670
Abstract
No abstract availableKeywords
Funding Information
- University of Florence
This publication has 33 references indexed in Scilit:
- Computational protein–ligand docking and virtual drug screening with the AutoDock suiteNature Protocols, 2016
- Modulation of Nerve Injury–induced HDAC4 Cytoplasmic Retention Contributes to Neuropathic Pain in RatsAnesthesiology, 2015
- Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation ratsJournal of the Formosan Medical Association, 2014
- Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)Expert Opinion on Therapeutic Patents, 2014
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- Epigenetics and the Modulation of NeuroinflammationNeurotherapeutics, 2013
- Neuroinflammation and the generation of neuropathic painBritish Journal of Anaesthesia, 2013
- Histone deacetylase inhibitors suppress immune activation in primary mouse microgliaJournal of Neuroscience Research, 2013
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Microglia-mediated neurotoxicity: uncovering the molecular mechanismsNature Reviews Neuroscience, 2007